Real-time enrollment status for this epilepsy clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:42 AM UTC
| NCT Number | NCT05518578 |
| Recruiting Status | Recruiting |
| Condition | Epilepsy |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Supernus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | April 21, 2026 (Apr 21, 2026) |
As of September 1, 2026: Clinical trial NCT05518578 is currently recruiting participants. This phase2 study for epilepsy is actively seeking new participants at 2 locations across the United States. The study is sponsored by Supernus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05518578 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05518578 was last updated Apr 21, 2026 (April 21, 2026). HelloStudys verifies this status automatically.